FDA Orders New Warnings on GLP-1 Diabetes Drugs After Rare Vision Loss Linked to Treatment
A new FDA-mandated safety label for GLP-1 agonist drugs highlights a rare but serious risk of vision loss, marking…
A new FDA-mandated safety label for GLP-1 agonist drugs highlights a rare but serious risk of vision loss, marking…